Trump administration must defend and protect U.S. innovation
PhRMA recentlysubmitted comments to the Office of the United States Trade Representative (USTR) ’sSpecial 301 Report, calling on the Trump administration to defend American biopharmaceutical innovators and jobs by ending market access and intellectual property barriers in 24 leading economies around the world.
Source: The Catalyst - Category: Pharmaceuticals Authors: Priscilla VanderVeer Tags: Intellectual Property 301 Report Trade Source Type: news